A Non‐Fetal Chronic Residual Inflammatory Liver Phenotype After Transient Abnormal Myelopoiesis in Down Syndrome

View at publisher Summarise with VIRAT
Authors: Koji Yokoyama, Hideki Kumagai, Akira Shimada
Cited by: 0
References: 13

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Transient abnormal myelopoiesis (TAM) in Down syndrome (DS) typically causes acute neonatal liver failure; however, late-onset chronic sequelae remain undercharacterized. We report two patients who, despite achieving hematologic remission, developed a persistent non-fatal inflammatory liver phenotype. Unlike the catastrophic neonatal hemochromatosis-like pathway, these cases exhibited sustained transaminase elevations and fibrotic markers triggered by immune bias rather than blast burden. We propose a two-track model of DS-TAM hepatic sequelae: (i) an acute fatal pathway, and (ii) a chronic residual inflammatory phenotype. These findings expand the clinical spectrum of TAM-associated liver disease, necessitating long-term hepatic surveillance beyond hematologic remission.

Fields of Study & Subjects

Pediatric Hepatobiliary Diseases and Treatments Down syndrome and intellectual disability research Acute Myeloid Leukemia Research

Publication details

Journal / source
Pediatric Blood & Cancer
Volume
73
Issue
6
Pages
e70280–e70280
Publication date
26 March 2026
Language
EN